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Different types of shock induce distinct metabolic
changes. The myocardium at rest utilizes free fatty
acids as its primary energy source, a mechanism that
changes to aerobic glycolysis during sepsis and is in
contrast to hemorrhagic shock. The immune system
also uses this mechanism, changing its substrate
utilization to activate innate and adaptive cells.
Cardiomyocytes share a number of features similar to
antigen-presenting cells and may use this mechanism
to augment the immune response at the reversible
expense of cardiac function.of the myocardium [2,3] and a shift in metabolic substrateCardiomyocyte metabolism changes in response to dif-
ferent types of shock. Chew and colleagues [1] in the
previous issue of Critical Care used microdialysis to
measure metabolites within cardiac and skeletal muscle
during endotoxemia. They found that endotoxemic
shock induces metabolic changes in cardiac and skeletal
muscle cells that do not occur during hemorrhagic
shock. In particular, myocardial and skeletal muscle
glucose concentrations were markedly decreased during
endotoxemic shock. While lactate increased in both
forms of shock, pyruvate levels also increased during
endotoxemia, suggesting that elevated lactate levels were
not due to anaerobic metabolism, in accord with the
observations of Cunnion and colleagues [2]. Muscle
pyruvate levels did not increase to the same extent dur-
ing hemorrhagic shock, suggesting that increased lactate
was linked to anaerobic metabolism occurring in this
form of shock.
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© 2013 BioMed Central Ltd.and re-demonstrated the metabolic flexibility of the
myocardium. The profoundly low local glucose concen-
tration in myocardium and skeletal muscle during
endotoxemic shock with preservation of the lactate to
pyruvate ratios suggests lactate utilization and/or differ-
ences in the Krebs cycle. Another interesting finding was
the ability of skeletal muscle to preserve the lactate to
pyruvate ratio during endotoxemic but not hemorrhagic
shock, reflecting again the different lactate fates and
perhaps the different mitochondrial densities between
myocardium and skeletal muscle.
Sepsis induces significant changes in myocardial metab-
olism, including a reduction in the oxygen extraction ratio
from using free fatty acids to increased utilization of
lactate. To understand the differences in myocardial and
skeletal muscle metabolism observed by Chew and
colleagues [1], we explore changes in substrate metabol-
ism observed during a septic inflammatory response.
Sepsis is unique amongst types of shock in that it is the
result of a complex interaction between the infecting
microorganism and the host immune, inflammatory and
coagulation responses. The host innate immune response is
triggered through interaction of pathogen molecules with
innate immune receptors with subsequent release of pro-
and anti-inflammatory cytokines, stimulation of adaptive
immunity, and activation of the coagulation system. Recent
data suggest that septic shock may have unique effects on
substrate utilization with accelerated glucose metabolism,
despite comparable pyruvate and lactate levels [1]. Revers-
ible cardiomyocyte hypocontractility also occurs, possibly
related to hibernation in order to maintain myocyte viabil-
ity by limiting oxygen consumption, energy requirements
and ATP. Whether a direct metabolic link connecting
metabolic substrates and contractility exists remains to be
demonstrated. It is notable, however, that Chew and col-
leagues [1] observed a significant drop in ejection fraction
and impaired ventricular relaxation.
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'omnivores', changing their energy substrate in response
to demand, ischemia and inflammatory stimuli. Prior
studies have demonstrated the alteration in oxidative
phosphorylation that occurs within mitochondria during
sepsis, despite adequate oxygen availability and the pres-
ervation of ATP [4]. This also occurs during ischemia,
likely from a different mechanism with intracellular ATP
maintained by increased aerobic glycolysis. Concur-
rently, glucose transporters GLUT1 and GLUT4 increase
glucose uptake with glycogen deposition in the cells [5].
The change in myocardial metabolism is not unique, but
also is a function of the immune system whereby immune
cells must switch from a resting quiescent state to an active
state. Accelerated rates of glycolysis can occur through
lipopolysaccharide activation of macrophages and dendritic
cells through Toll-like receptor 4 (TLR4) in M1 inflamma-
tory macrophages and T-helper 17 lymphocytes [6,7]. On
the other hand, cells that limit inflammation, such as regu-
latory T cells, M2 anti-inflammatory macrophages and qui-
escent memory T cells that carry the CD8 antigen, exhibit
oxidative metabolism with more limited rates of glycolysis
[8,9]. This process is very energy demanding and it has
been shown that activated T cells can increase glucose up-
take 20- to 40-fold in preparation to divide [10]. Amino
acid and lipid metabolism is suppressed in order to permit
cell expansion and hexokinase activity is increased, an en-
zyme involved in both glycolysis and the catabolic pentose
phosphate pathway [11]. Free fatty acids are also activators
of NF-κB throughTLR4 signaling in adipocytes and skeletal
muscle, and may have a similar effect in the myocardium
[12]. Therefore, aerobic glycolysis is required for immune
activation of macrophages, dendritic cells and T-cell effec-
tors, but has little effect on cell proliferation or survival [6].
In activated T cells, this process may be regulated by
GADPH binding to AU-rich elements in interferon-γ
mRNA, thereby controlling its cytokine translation [13].
Cardiomyocytes share a number of features analogous to
the antigen-presenting cells, including expression of TLRs
[14,15]. In response to TLR activation, cardiomyocytes ex-
press many pro- and anti-inflammatory molecules, includ-
ing cytokines (for example, tumor necrosis factor-α,
interleukin-1β), chemokines, cell surface adhesions mole-
cules, triggering of apoptotic pathways and increased ex-
pression of calcium channel binding proteins. Intercellular
adhesion molecule 1 binds the cardiomyocyte cytoskeleton,
disrupting normal intracellular calcium release and
resulting in decreased contractility [16]. Calcium channel
binding proteins S100A8 and S100A9 bind to the sarco-
plasmic reticulum calcium channel SERCA2, further de-
creasing contractility [17]. Lastly, extracellular heat shock
protein 70 acts through TLR2 to activate NF-κB and de-
crease contractility [18]. Therefore, it is not surprising that
the changes in myocardial metabolism observed during theseptic inflammatory response may share features with
changes in metabolism observed in inflammatory cells. It is
conceivable that changes in substrate metabolism observed
in cardiomyocytes may be due to mechanisms shared with
other inflammatory cells. Whether the myocardium de-
creases contractility to reflect the relatively inefficient
process of aerobic glycolysis remains to be solved.Abbreviations
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